Pricing Log in Create free account
Saturday 17 October 2026 Export COR’s income statement to Excel — free account

Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Cencora, Inc. (COR) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Cencora, Inc. (COR) trades at a EV/EBITDA of 18.2×. Over the past ten years it has ranged from 0.0× (September 2021) to 334× (April 2015); the current reading is higher than 85% of that period. That is in line with the Medical Distribution industry median of 17.8× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 17.3× 23.91%
FY2024 13.9× 20.43%
FY2023 11.6× 16.68%
FY2022 9.9× 0.18%
FY2021 9.9× —
FY2020 0.0× —
FY2019 11.4× 2.95%
FY2018 11.1× (15.11%)
FY2017 13.1× 33.17%
FY2016 9.8× (70.04%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 15.5× (16.75%)
Mar 2026 18.6× (3.35%)
Dec 2025 19.2× 11.23%
Sep 2025 17.3× 2.95%
42 more quarters

Against its own ten years

Low 0.0× High 334×
Ten-year median 12.6×
Current reading's percentile 85

EV/EBITDA against peers

Company EV/EBITDA
HKPD Cellyan Biotechnology Co., Ltd compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
COSM Cosmos Health Inc. compare n/m
ACH Accendra Health, Inc. compare 8.1×
HSIC Henry Schein, Inc. compare 12.0×
MCK McKesson Corporation compare 17.8×
CAH Cardinal Health, Inc. compare 17.9×
COR Cencora, Inc. 18.2×
Medical Distribution industry median 17.8×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on COR